Table 2: Change in hemoglobin and hematocrit in ESRD and chronic HD patients treated with AG.

 

Before

After

3rd month

6th month

One year

Hb (g/L)

1 p

11.3 ± 0.8

11.6 ± 1.9

11.5 ± 0.9

11.0 ± 1.6

 

2 p

10.3 ± 0.3*

11.3 ± 1.5

11.6 ± 1.7

10.9 ± 0.5

Ht (%)

1 p

34% ± 2%

35% ± 6%

35% ± 3%

33% ± 5%

 

2 p

31% ± 1%*

35% ± 4%

36% ± 6%

34% ± 2%

The data are expressed as mean ± standard deviation.*: P < 0.05 compared between the one powder and the two powders groups

Hb: Hemoglobin; Ht: Hematocrit; 1 p: One powder AG; 2 p: Two powders AG.